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Tbx2 is a member of a large family of transcription factors defined by homology to the T-box DNA-binding domain. Tbx2
plays a key role in embryonic development, and in cancer through its capacity to suppress senescence and promote
invasiveness. Despite its importance, little is known of how Tbx2 is regulated or how it achieves target gene specificity.
Here we show that Tbx2 specifically associates with active hypophosphorylated retinoblastoma protein (Rb1), a known
regulator of many transcription factors involved in cell cycle progression and cellular differentiation, but not with the
Rb1-related proteins p107 or p130. The interaction with Rb1 maps to a domain immediately carboxy-terminal to the T-box
and enhances Tbx2 DNA binding and transcriptional repression. Microarray analysis of melanoma cells expressing
inducible dominant-negative Tbx2, comprising the T-box and either an intact or mutated Rb1 interaction domain, shows
that Tbx2 regulates the expression of many genes involved in cell cycle control and that a mutation which disrupts the
Rb1-Tbx2 interaction also affects Tbx2 target gene selectivity. Taken together, the data show that Rb1 is an important
determinant of Tbx2 functional specificity.
INTRODUCTION
Members of the T-box family of transcription factors play
important roles in the regulation of cell fate decisions and
morphogenesis during development. For example, the pro-
totypical T-box factor, brachyury, is essential for mesoderm
induction (Herrmann et al., 1990), Tbx4 and Tbx5 determine
limb identity (Rodriguez-Esteban et al., 1999; Takeuchi et al.,
1999), T-pit is a specifier of pituitary fate (Pulichino et al.,
2003), and T-bet controls commitment to the T helper type 1
lineage (Szabo et al., 2000). In addition, Tbx2 determines
ventral tubero-mamillary (vt-m) hypothalamic identity, is
essential for outflow tract morphogenesis and atrioventric-
ular canal patterning during cardiogenesis and is involved
in specifying posterior digit identity (Harrelson et al., 2004).
Several T-box genes are also involved in the progression
of cancer. Tbx2 and the highly related Tbx3 are amplified
and/or overexpressed in a subset of breast cancers and in
melanoma (Sinclair et al., 2002; Hoek et al., 2004; Jonsson et
al., 2007). Tbx2 is additionally overexpressed in pancreatic
cancer cell lines (Mahlamaki et al., 2002), whereas Tbx3 is
implicated in ovarian and uterine cervical cancer (Lom-
nytska et al., 2006; Lyng et al., 2006). These proteins have
been proposed to promote cancer progression through sev-
eral different mechanisms. Tbx2 and Tbx3 have been shown
to cooperate with active Ras to promote anchorage-indepen-
dent growth and transform mouse embryo fibroblasts (Carl-
son et al., 2002; Vormer et al., 2008), whereas Tbx3 can
function to enhance melanoma invasiveness by down-regu-
lating expression of the E-cadherin cell–cell adhesion pro-
tein (Rodriguez et al., 2008). Tbx2 is also required to main-
tain proliferation and suppress senescence in melanomas by
repressing expression of the p21CIP1 cyclin-dependent ki-
nase (cdk) inhibitor (Vance et al., 2005), and Tbx2 and Tbx3
can block premature senescence of mouse striatal cells in
culture by either directly repressing p19ARF (Jacobs et al.,
2000; Lingbeek et al., 2002) or p21CIP1 (Prince et al., 2004).
Despite the discovery that T-box transcription factors are
important regulators of development and disease the molec-
ular mechanisms of transcriptional control by these proteins
are relatively unknown. Identifying interacting proteins and
associated activities is therefore essential to understand T-
box factor mode of action. To date, several lines of evidence
suggest that T-box factors can function through epigenetic
mechanisms. T-bet is able to recruit histone H3K4 methyl-
transferase and H3K27 demethylase activities to regulate
transcription (Lewis et al., 2007; Miller et al., 2008). This
interaction is mediated by conserved amino acids in the
T-box and may be a general feature of the family. Accord-
ingly, the distantly related Tbx6 and Brachyury proteins can
induce H3K4me2 at target genes and Eomes, Brachyury, and
Tbx5 also interact with H3K27 demethylase activity. In ad-
dition, the pituitary specific T-box factor Tpit recruits the
SRC/p160 histone acetyltransferase to regulate hormone de-
pendent transcription from the proopiomelanocortin (POMC)
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promoter (Maira et al., 2003). Furthermore, Tbx2 specifically
binds the histone H3 amino-terminal tail (Demay et al., 2007)
and interacts with histone deacetylase (HDAC) activity to
repress transcription and can recruit HDAC1 to target pro-
moters (Vance et al., 2005). The function of T-box family
members can also be regulated by their associated cofactors.
The Ripply family of proteins interact with the zebrafish
Brachyury and Tbx24 orthologues (Kawamura et al., 2008)
and the Xenopus Tbx1 and Tbx6 proteins (Hitachi et al., 2009).
Ripply binding recruits a Groucho/TLE corepressor com-
plex containing HDAC activity, which functions to convert
these transcription factors from activators into repressors.
The retinoblastoma tumor suppressor protein (Rb1) asso-
ciates with a wide range of transcription factors to control
cell cycle progression, cellular senescence, apoptosis, and
differentiation. Rb1 mediates these effects by modulating the
function of its interacting transcription factors. The best
characterized role for Rb1 is in the control of E2F1 activity to
negatively regulate cellular proliferation. Rb1 exerts this
function by interfering with the ability of E2F1 to commu-
nicate with the basal transcription apparatus and/or recruit-
ing chromatin modifying enzymes to block the activation of
E2F responsive genes (Brehm and Kouzarides, 1999). In this
context Rb1 has been shown to target HDACs (Brehm et al.,
1998; Magnaghi-Jaulin et al., 1998), histone and DNA meth-
yltransferases (Robertson et al., 2000; Nielsen et al., 2001),
and components of ATP-dependent chromatin remodeling
complexes (Dunaief et al., 1994; Trouche et al., 1997) to ac-
tively repress E2F transcription. In addition to its role in E2F
regulation, Rb1 has been shown to interact with transcrip-
tion factors that function in cellular differentiation such as
C/EBP, NFIL-6, and c-jun (Chen et al., 1996a,b; Nead et al.,
1998). Rb1 enhances the transcriptional activity of these
factors by stimulating DNA binding. Furthermore, Rb1 in-
teracts with p120E4F (E4F), a GLI-Kruppel–related transcrip-
tion factor involved in cell cycle control, increasing both E4F
binding to DNA and E4F-mediated transcriptional repres-
sion (Fajas et al., 2000). Taken together these studies show
that Rb1 has the ability to inhibit or enhance the transcrip-
tional activity of its interacting proteins by a variety of
mechanisms.
Here we show that Rb1 modulates the function of the
Tbx2 transcription factor. The results provide mechanistic
insights into Tbx2 transcriptional control and reveal a mo-
lecular link between two families of proteins involved in
normal development and dysregulated in cancer.
MATERIALS AND METHODS
Plasmid Constructs
pGEX2TK-Tbx2(1-361) and pGEX2TK-Tbx2(361-701) vectors have been de-
scribed previously (Vance et al., 2005). Further glutathione S-transferase (GST)
Tbx2 expression vectors were generated by PCR cloning Tbx2 amino acids
84-366, 84-316, 84-301, 84-287, and 84-262 from pCMV-Tbx2 (Prince et al., 2004) as
BamHI-BglII fragments into pGEX2TK. pGEX-Rb(379-928) and the RB1 expres-
sion vector were kind gifts from S. Mittnacht (Institute of Cancer Research,
London). To generate pIVEX-Rb(379-928) Rb amino acids 379-928 were sub-
cloned as a BamHI fragment from pGEX-Rb(379-928) into pIVEX. The p21CIP1-
luciferase reporter contains a 2.2-kb SacI-HindIII fragment of the human p21CIP1
promoter described in Prince et al. (2004) inserted upstream of the luciferase gene
in pGL3 (Promega, Madison, WI). pCMV-Tbx2L294AL296A, pGEX2TK-
Tbx2L294A,L296A, pGEX2TK-Tbx2(84-301)L294A,L296A, and pBabeHAER-
Tbx2(1-301L294A,L296A) mutant constructs were generated with the
QuikChangeII Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according
to the manufacturer’s instructions using pCMV-Tbx2 (Prince et al., 2004),
pGEX2TK-Tbx2, pGEX2TK-Tbx2(84-301), and pBabeHAER-Tbx2(1-301) (Vance
et al., 2005) as templates, respectively.
Pulldown Assays and Immunoprecipitations
GST fusion proteins were expressed in Escherichia coli strain BL21(DE3) pLysS
as described in Aksan and Goding (1998). His-tagged proteins were expressed
using the cell-free Rapid Translation System (Roche, Indianapolis, IN) and
purified under native conditions using the Ni-NTA Spin Kit (Qiagen, Chats-
worth, CA) both according to the manufacturer’s instructions. GST pulldown
assays were performed as shown in Yavuzer et al. (1995), and immunopre-
cipitation experiments were carried out as described (Carreira et al., 2005)
using 10 l mouse anti-Tbx2 (Prince et al., 2004) or anti-SV5 monoclonal
(Serotec, Oxford, United Kingdom) antibodies and 50 l protein G Sepharose
to capture the immune complexes.
Western Blotting
Cell extractions using cytoskeleton (CSK) buffer (10 mM Pipes-KOH, pH 7.0,
100 mM NaCl, 300 mM sucrose, 3 mM MgCl2) plus 0.5% Triton X-100 were as
described (Martini et al., 1998). Alternatively, cells were lysed directly in
SDS-PAGE loading buffer, sonicated, and boiled for 5 min. Proteins were
resolved on SDS-PAGE gels and then transferred onto Hybond C (Amersham,
Piscataway, NJ) membranes. To separate the different phosphorylated forms
of Rb we used a polyacrylamide/bisacrylamide ratio of 200:1. Membranes
were probed with appropriate primary antibodies, detected using peroxidase-
conjugated secondary antibodies, and visualized by enhanced chemilumines-
cence (Amersham). Antibodies used were anti-human Rb1 mouse monoclonal
(PharMingen, San Diego, CA), anti-HA (Clone HA-7, Sigma, St. Louis, MO),
anti-p107, anti-p130, anti-tubulin, anti-extracellular signal-regulated kinase
(ERK)-2 rabbit polyclonals and anti-GST mouse monoclonal (all Santa Cruz
Biotechnology, Santa Cruz, CA).
Immunofluorescence Microscopy
To characterize the B16 HAER-Tbx2–expressing cell lines immunofluores-
cence staining was performed using an anti-hemagglutinin (HA; Clone HA-7,
Sigma) mouse mAb as described in Vance et al. (2005). For the colocalization
studies, cells grown on coverslips were washed with PBS (phosphate-
buffered saline containing 0.5 mM MgCl2 and 0.5 mM CaCl2) and then with
CSK buffer to extract soluble proteins. Cells were then incubated in CSK
buffer supplemented with 0.5% Triton X-100 and protease inhibitor cocktail
(Roche) for 5 min at room temperature. After two washes in CSK buffer, the
cells were fixed in 4% paraformaldehyde for 10 min at room temperature
before permeabilization using 0.5% Triton X-100 for 6 min at room tempera-
ture. Coverslips were then incubated with anti-Tbx2 mouse monoclonal and
anti-Rb1 rabbit polyclonal (Santa Cruz) antibodies, washed three times with
PBS, and then incubated with both anti-mouse Texas Red and anti-rabbit
FITC secondary antibodies (Vector Laboratories, Burlingame, CA). Cells were
washed again with PBS and mounted using Vectashield mounting medium.
We imaged a single optical section using a Zeiss Axiovert 135 microscope
with a PlanApoChromat 63 1.40 NA oil objective (Thornwood, NY).
Electrophoretic Mobility Shift Assays
Binding reactions were performed with purified GST-Tbx2 fusion proteins
and 32P-labeled T-element oligonucleotide probes and resolved on a 6%
polyacrylamide gel as described previously (Carreira et al., 1998). The follow-
ing sequence of the double-stranded consensus T-element oligonucleotide
was used: 5-ctagaGGGAATTTCACACCTAGGTGTGAAATTCCCt-3 (un-
derlined sequences designate a palindromic T-box binding site). For the
supershift experiment purified proteins were preincubated with anti-Rb1
rabbit polyclonal antibody (C-15, Santa Cruz) for 1 h at room temperature
before addition of the probe.
Cell Culture and Luciferase Assays
B16, Phoenix, SAOS-2, and HeLa cells were grown in DMEM supplemented with
10% fetal bovine serum and 1% penicillin streptomycin. B16 cells expressing the
estrogen receptor (ER) fusion proteins were generated and characterized as
described in Vance et al. (2005). ER fusion proteins were activated by the addition
of 4-hydroxy tamoxifen (4-OHT) to a final concentration of 300 nmol/l. For
transcription assays 2.5  104 cells were seeded per well in a 24-well plate. The
next day cells were transfected with reporter constructs and expression vectors
using FuGENE 6 (Roche) according to the manufacturer’s instructions. pCMV-
-gal expression vector (25 ng) was also included to normalize for transfection
efficiency. We used 50 ng pGL3-p21CIP1pro, 25 ng and 50 ng of either pCMV-
Tbx2 or pCMV-Tbx2L294AL296A plasmids, and 100 ng Rb expression vector.
The total amount of DNA was made equal in each case by the addition of empty
pCMV vector. Forty-eight hours after transfection lysates were prepared and
assayed for luciferase and -galactosidase activity. All transfections were re-
peated at least three times in duplicate.
Microarrays
Total RNA was isolated from ER-Tbx2(1-301) and ER-Tbx2(1-301mt) cells grown
in the absence or presence of ligand for 24 h using the Qiagen Mini RNeasy kit.
The quality of the RNA was assessed on a Bioanalyzer (Agilent Technologies,
Wilmington, DE) . Total RNA (150 ng) was labeled using the GeneChip 3 IVT
Express Kit (Affymetrix, Santa Clara, CA) according to the manufacturer’s in-
structions. Fragmented cRNA (15 g) was then hybridized to the mouse Af-
fymetrix MOE430A expression array. The hybridization mix was preserved and
subsequently hybridized to the MOE430B array. Chips were washed, stained,
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and scanned using the GeneChip Scanner 3000 7G (Affymetrix). Microarrays
were performed in triplicate for each experimental condition.
Microarray Analysis
We used the updated chip definition files provided on the brainarray and NuGO
Web pages to correct for updated gene annotations that were not available when
the microarrays were designed (custom-CDFs and annotations for moe430 ver-
sion 12.0.0; http://brainarray.mbni.med.umich.edu/Brainarray/Database/ Cus-
tomCDF/12.0.0/entrezg.asp and http://nugo-r.bioinformatics.nl/Packages_
Prior_to_R2.10.html). Use of updated annotations has been shown to make a
significant improvement to the accuracy of microarray data analysis (Dai et
al., 2005). A tool called Harshlight (http://www.bioconductor.org/packages/
2.2/bioc/html/Harshlight.html) was applied to remove the effects of spatial
blemishes on the arrays (Suarez-Farinas et al., 2005). We used GeneChip
Robust Multiarray Average (GCRMA; http://www.bioconductor.org/pack-
ages/2.2/bioc/html/gcrma.html) to do background correction because this
method removes the bias introduced by nucleotide content of probes (Naef and
Magnasco, 2003). Harshlight, GCRMA, quality controls, principal component
analysis, differential gene expression, GO (gene ontology)-term analyses, and
heat maps were done by developing small R functions based on the tools of the
Bioconductor package (http://www.bioconductor.org/; Gentleman et al., 2004).
RESULTS
Tbx2 Binds the Retinoblastoma Tumor Suppressor Protein
The Tbx2 transcription factor plays an important role in
embryonic development and is mis-expressed in several
cancers (Jacobs et al., 2000; Harrelson et al., 2004; Vance et al.,
2005). However, the molecular mechanisms underlying the
function of Tbx2 in transcriptional control remain poorly
understood. Because the Rb-family of transcriptional cofac-
tors, comprising Rb1, p107, and p130, are known to regulate
the activity of many different transcription factors involved
in controlling cell cycle progression and differentiation, we
sought to determine whether they can associate with Tbx2
and modulate its activity.
To do this, a series of GST pulldown experiments were first
carried out to determine if Tbx2 can interact with Rb1. Figure
1A shows that in vitro–translated Tbx2 interacts with the Rb1
large pocket domain (Rb379-928) but not with GST alone. This
region of Rb1 mediates its tumor suppressor function and is
responsible for the interaction with the majority of its cellular
partners (for a review see Morris and Dyson, 2001). In addition,
the T-box–containing amino-terminal region of Tbx2 (amino
acids 1-361) when fused to GST purifies Rb1 from HeLa nu-
clear extract in a pulldown assay (Figure 1B). No binding was
detected when a carboxy-terminal fragment of Tbx2 (amino
acids 361-701) containing the transcriptional repression and
HDAC1-interaction domain or GST alone were used as a bait.
We next assessed the specificity of Tbx2 to target different
Rb1-related pocket proteins. The results of this analysis are
presented in Figure 1B and show that Tbx2 specifically inter-
acts with Rb1 and does not purify p130 and p107 from HeLa
nuclear extract. We further characterized the interaction by
separating the phosphorylated forms of Rb1 in complex with
Tbx2. This showed that Tbx2 binds a fast-migrating hypophos-
phorylated form of Rb1 and that slower migrating phosphor-
ylated forms of Rb1 were still detected in the unbound extract
(Figure 1C). This is consistent with the work from different
laboratories showing that cell cycle–dependent phosphoryla-
tion inactivates Rb1 and disrupts the interaction with many of
its protein partners (see Mittnacht, 1998 for a review). Finally,
experiments using purified proteins (Figure 1D) indicate that
Tbx2 binds directly to Rb1 as His-Rb(379-928) interacts with
GST-Tbx2(1-361) and not GST alone. Taken together, these data
show that the Tbx2 transcriptional factor specifically associates
with active hypophosphorylated Rb1 in vitro.
Tbx2 Interacts with Rb1 in Melanoma Cells
Tbx2 is overexpressed in melanomas when compared with
primary melanocytes and melanocyte cell lines (Vance et al.,
2005), whereas Rb1 is necessary for both postnatal melano-
cyte survival (Yu et al., 2003; Carreira et al., 2005) and senes-
Figure 1. Tbx2 directly interacts with hypophosphorylated Rb1. The
indicated GST fusion proteins were immobilized on glutathione beads
and incubated with either 35S-labeled IVT Tbx2 (A), HeLa nuclear
extract (B and C), or purified HisRb(379-928) protein (D). After exten-
sive washing, bound proteins were separated by SDS-PAGE and visu-
alized either by autoradiography (A) or Western blotting (B–D). Tbx2
associates with Rb1 in B16 melanoma cells (E). Lysates from B16 cells
were prepared and immunoprecipitated using either anti-Tbx2 or an
unrelated control mAb. Proteins in the complex were identified by
Western blotting using anti-Rb1 (top) or anti-Tbx2 antibody (bottom).
(F) Immunofluorescence staining of B16 cells using anti-Tbx2 and
anti-Rb1 antibodies after salt extraction of soluble proteins.
K. W. Vance et al.
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cence in melanocytes in culture and melanocytic nevi in vivo
(Bandyopadhyay and Medrano, 2000; Michaloglou et al.,
2005). To expand on our in vitro binding data and determine
whether endogenous Tbx2 and Rb1 interact in cells in cul-
ture an anti-Tbx2 mAb was used to immunoprecipitate pro-
tein complexes from B16 mouse melanoma cells. The results
of this analysis are shown in Figure 1E and reveal that Tbx2
coimmunoprecipitates with Rb1, whereas no association
was detected using a control antibody. Indirect immunoflu-
orescence staining was also carried out to provide additional
evidence that Tbx2 and Rb1 interact in the melanocyte lin-
eage and showed that Tbx2 and Rb1 partially colocalize in
distinct nuclear foci in B16 melanoma cells after extraction of
soluble proteins (Figure 1F). Previous analysis of Tbx2 sub-
cellular localization demonstrating that Tbx2 protein is as-
sociated with DNA in subnuclear foci and excluded from
pericentric heterochromatin is consistent with these results
(Bilican and Goding, 2006). Taken together these data show
that Tbx2 and Rb1 interact in vitro and in living cells and
suggest that Rb1 may be able to modulate the function of
Tbx2.
Tbx2 Binds Rb1 in a LXCXE-independent Manner
Rb1 has been shown to interact with many of its associated
proteins via an LXCXE motif (reviewed in Morris and
Dyson, 2001). However, examination of the Tbx2 amino acid
sequence revealed that this motif is not present in Tbx2. We
therefore performed GST pulldown assays using HeLa nu-
clear extract and a panel of GST-Tbx2 deletion mutants to
map the Rb1 interaction domain (Figure 2A). Removal of the
amino-terminal 83 amino acids of Tbx2 had no effect on Rb1
binding. However, successive carboxy-terminal truncations
of the Tbx2(84-301) protein revealed that deletion of Tbx2
amino acids 301-287 immediately C-terminal to the T-box
greatly reduces the interaction between Tbx2 and Rb1. Anal-
ysis of the Tbx2 amino acid sequence from 287 to 301 iden-
tified two hydrophobic leucine residues at positions 294 and
296 that could potentially be involved in forming protein–
protein interactions. We therefore generated a mutated GST
fusion protein containing leucine-to-alanine changes at po-
sitions 294 and 296 within the smallest fragment of Tbx2
(amino acids 84-301) that can bind Rb1. The resultant GST-
Tbx2(84-301)L294AL296A protein failed to interact with Rb1
from HeLa nuclear extract in a pull-down experiment (Fig-
ure 2B) but retained the ability to bind DNA (Figure 2C) in
a bandshift assay in which either purified wild-type or mu-
tated GST-Tbx2(83-301) fusion proteins were incubated with
a consensus T-element probe. Taken together, these results
show that the L294AL296A mutation specifically disrupts
the interaction between Tbx2 and Rb1 without affecting
overall Tbx2 protein conformation.
Rb1 Enhances the Ability of Tbx2 to Repress
Transcription
The Rb1 protein can function as a transcriptional corepres-
sor. To determine whether Rb1 plays a role in Tbx2-medi-
ated transcriptional control, we first assayed the ability of
the wild-type Tbx2 and Tbx2 L294AL296A proteins to reg-
ulate p21CIP1. Tbx2 is known to directly repress p21CIP1
expression through a T-element half site located near the
p21CIP1 initiator region (Prince et al., 2004). To do this, we
cotransfected Phoenix cells, a derivative of HEK-293 cells,
which do not express Tbx2, with a human p21CIP1 promoter-
luciferase reporter and increasing concentrations of either
Tbx2 or Tbx2L294AL296A expression vector. The results are
shown in Figure 3A and reveal that wild-type Tbx2 re-
pressed p21CIP1 promoter activity by up to threefold. The
non-Rb1 binding Tbx2 mutant protein has a much reduced
ability to regulate p21CIP1 and only repressed p21CIP1 ex-
pression up to a maximum of 1.4-fold. Western blotting
showed that the wild-type and mutant Tbx2 proteins were
expressed to similar levels. Additional evidence of a role for
Rb1 in the modulation of Tbx2 function is provided in
Figure 3B. This showed that cotransfection of an Rb1 expres-
sion vector further increases Tbx2-dependent repression of
the p21CIP1 promoter in Phoenix cells. Although Tbx2 alone
repressed p21CIP1 activity about fourfold in this set of ex-
periments p21CIP1 levels were repressed ninefold in the
presence of Rb1. The addition of Rb1 did not stimulate the
ability of the Tbx2L294AL296A mutant protein to repress
p21CIP1, and Rb1 alone did not regulate p21CIP1activity.
Western blotting additionally showed that Rb1 overexpres-
sion does not affect the levels of the transfected Tbx2 pro-
teins. This demonstrates that the ability of Tbx2 to repress
expression of a known target gene is sensitive to the levels of
Rb1. Although we cannot rule out that an interaction be-
tween Tbx2 and other factors, in addition to Rb1, is abol-
ished by the L294AL296A mutation, the results show that
Tbx2-mediated transcriptional repression of p21CIP1 expres-
sion correlates with its capacity to interact with Rb1.
To provide further proof that Rb1 functions as a transcrip-
tional corepressor for Tbx2, we assayed the ability of the
Figure 2. Mapping the Rb1 interaction domain in Tbx2. (A) Dele-
tion of Tbx2 amino acids 301-287 greatly reduces binding to Rb1. (B)
Identification of a Tbx2 mutant protein that fails to bind Rb1. The
indicated GST-Tbx2 deletion mutants immobilized on glutathione
beads were incubated with HeLa nuclear extract in a pulldown
assay. Proteins were detected by Western blotting using anti-Rb1
and anti-GST antibodies. Tbx2 L294AL296A mutant protein is able
to bind DNA (C). Equal amounts of purified GST-Tbx2(84-301) and
GST-Tbx2(L294A,L296A) fusion proteins were incubated with ra-
diolabeled T-element as a probe in a band-shift assay.
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wild-type and L294AL296A Tbx2 proteins to regulate
p21CIP1 reporter activity in Rb1-negative SAOS-2 cells. Strik-
ingly, the results revealed that Tbx2 functions to enhance
p21CIP1 promoter activity in cells lacking Rb1 with both the
wild-type and non-Rb1–binding mutant Tbx2 proteins acti-
vating p21CIP1 expression about threefold at high concentra-
tions of expression vector (Figure 3C). Although previous
deletion mapping experiments have suggested that Tbx2
contains a transcriptional activation domain (Paxton et al.,
2002), this is the first time that Tbx2 has been shown to
activate expression of a known target gene. Additionally, the
ability of the L294AL296A mutation to specifically disrupt
the interaction with Rb1 is supported by the finding that
there is no difference in the capacity of the wild-type and
mutant Tbx2 proteins to regulate p21CIP1 expression in these
cells. Although the result could add strength to our data,
suggesting that Rb1 is involved in Tbx2-mediated repres-
sion, it is difficult to draw this conclusion given that other
aspects of the cell background are so different. Moreover,
our attempts to convert Tbx2-mediated activation of p21 to
repression by reintroduction of Rb1 into these cells were
confounded by the observation that in these cells, Rb1 alone
showed a strong nonspecific activation of the p21CIP1 pro-
moter in the absence of exogenous Tbx2 (data not shown).
Rb1 Increases the DNA-binding Activity of Tbx2
Because Rb1 can modulate the activity of its interacting
transcription factors in a number of different ways, we tested
the ability of Rb1 to regulate the DNA-binding function of
Tbx2 in a bandshift assay. The results of this experiment are
displayed in Figure 3D. Lane 1 shows the binding of sub-
optimal levels of purified GST-Tbx2 protein to the T-element
probe. Binding is specific, because the retarded complexes
could be competed with excess of a nonlabeled T-element
competitor (lane 2) but not with an unrelated oligonucleo-
tide (lane 3). Adding increasing levels of purified His-
Rb(379-928) to the bandshift reaction enhanced the bind-
ing of Tbx2 to its consensus site (lanes 4 and 5), whereas
Rb1 alone did not bind DNA (lanes 6 and 7). This effect is
specific as it is abolished by the L294AL296A mutation as
Rb1 did not stimulate the DNA-binding activity of a GST-
Tbx2L294AL296A fusion protein (lanes 8–10) and is not due
to nonspecific mass action of increased protein in the reac-
tion (Supplemental Figure 1). In addition, lanes 11–13 show
that we were unable to supershift the specific T-element
DNA protein complex using an anti-Rb1 antibody. A similar
inability to obtain a Rb1 supershift has been described before
in studies of Rb1-dependent stimulation of DNA binding by
c-jun, C/EBP, NF-IL6, and E4F (Chen et al., 1996a,b; Nead et
al., 1998; Fajas et al., 2000). It is therefore possible that Rb1
increases the DNA-binding activity of these transcription
factors by a common mechanism involving a transient in-
teraction that facilitates or stabilizes the interaction with the
DNA.
These biochemical data are consistent with the results of
our reporter assays showing that the non-Rb1 binding Tbx2
mutant has an impaired transcriptional repression function.
Taken together, they suggest that Rb1 can enhance the func-
tion of Tbx2 as a transcriptional repressor by increasing its
ability to interact with its cognate DNA recognition se-
quence.
Rb1 Modulates Tbx2 Target Gene Recognition
We previously showed that an ER-Tbx2(1-301) fusion pro-
tein containing amino acids 1-301, encompassing the T-box
(amino acids 84-287) and adjacent sequence, fused to the
ligand-binding domain of the estrogen receptor is able to
Figure 3. Tbx2 protein that does not bind Rb1 has an impaired
transcriptional repression function (A). Phoenix cells were transfected
with 50 ng p21CIP1 promoter luciferase reporter and either 25 ng or 50
ng of wild-type Tbx2 or Tbx2 L29AL296A expression vectors. Cotrans-
fection of Rb1 enhances Tbx2-mediated transcriptional repression (B).
Phoenix cells were cotransfected with 50 ng p21CIP1 promoter reporter
construct along with the indicated combinations of either Tbx2 (50 ng),
Tbx2mt (50 ng), and/or Rb1 (100 ng) expression vectors. Tbx2 activates
transcription in Rb1 negative cells (C). SAOS-2 cells were transfected
with 50 ng p21CIP1 promoter luciferase reporter and either 25 ng or 50
ng of wild-type Tbx2 or Tbx2 L29AL296A expression vectors. For these
reporter experiments cells were assayed for luciferase and -galacto-
sidase activity 48 h after transfection. pCMV--gal (25 ng) was used as
a transfection control and empty pCMV vector was added to make the
total amount of transfected DNA equal in each case. Western blotting
using anti-Tbx2, ant-Rb1, and anti-ERK antibodies was used to deter-
mine the levels of the transfected proteins. Rb1 increases the ability of
Tbx2 to bind DNA (D). The indicated combinations of purified GST-
Tbx2, GST-Tbx2(L294A,L296A), and His-Rb(379-928) proteins were in-
cubated in a band-shift assay using radiolabeled T-element as a probe.
Excess unlabeled T-element and Brn-2 oligos were used to assess the
specificity of binding. For the supershift experiment purified proteins
were incubated with 1 l anti-Rb1 rabbit polyclonal antibody before
addition of the probe.
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bind DNA and displace endogenous Tbx2 complexes from
their target promoters in mouse and human melanoma cells
(Vance et al., 2005). Our biochemical analysis mapping the
Rb1 interaction domain to amino acids immediately C-ter-
minal to the T-box coupled with the finding that Rb1 in-
creases the ability of Tbx2 to bind DNA in a bandshift
reaction suggests that Rb1 may play a role regulating Tbx2
target gene recognition and specificity.
To explore this possibility, we generated B16 cell lines ex-
pressing either the ER-Tbx2(1-301) protein or an ER-Tbx2(1-
301) mutant containing the non-Rb1 binding L294AL296A sub-
stitution. In contrast to the wild-type Tbx2(1-301) fragment the
DNA-binding activity of the mutant protein on the consensus
T-element is not enhanced by Rb1 when tested in a bandshift
assay (Figure 4A). The cell lines we established were screened
by Western blotting and indirect immunofluorescence to de-
termine the expression levels and the subcellular localization of
the fusion proteins. Figure 4B shows that we were able to
generate two clonal lines expressing the ER-Tbx2(1-301) and
ER-Tbx2(1-301mt) proteins to similar levels after 4-hydrota-
moxifen (4-OHT) induction. The ER fusion proteins have a
cytoplasmic localization in the absence of ligand but translo-
cate to the nucleus within 24 h after 4-OHT addition, demon-
strating that their activity can be tightly regulated (Figure 4C).
We next carried out expression profiling to first identify
genes whose expression changes after induction of ER-
Tbx2(1-301) and subsequently to identify targets whose mis-
regulation is dependent on the ability of Tbx2 to bind Rb1.
To do this, RNA was extracted and labeled from ER-Tbx2(1-
301) and ER-Tbx2(1-301mt) cells grown in the absence or
presence of ligand for 24 h and hybridized to Affymetrix
mouse MOE430 expression arrays. Statistical analysis iden-
tified 431 genes whose expression are significantly different
(tt  0.0001) after ER-Tbx2(1-301) induction. One hundred
sixty-six of these genes were up-regulated, and 265 genes
were down-regulated in response to ER-Tbx2(1-301) activa-
tion (see Supplemental Figure 2 for the full list). These
included previously identified Tbx2 targets such as con-
nexin43, whose expression is directly regulated through two
Tbx2-binding sites in its proximal promoter (Chen et al.,
2004), the helix loop helix transcription factor ID2, the Wnt
target ENC1, and the cdc2a and MAD2 cell cycle regulators,
which have been identified in previous microarray analyses
(Chen et al., 2001; Butz et al., 2004). Additionally, this anal-
ysis identified 18 potential Tbx2 target genes that have pre-
viously been shown to be repressed by Rb1 (Table 1; Markey
et al., 2002). This is consistent with the finding that Rb1 can
associate with and regulate Tbx2 function.
Comparison of the gene expression signatures of ER-
Tbx2(1-301) and ER-Tbx2(1-301mt) cells grown in the pres-
ence of ligand for 24 h identified a total of 415 genes whose
expression changes after ER-Tbx2(1-301) induction relative
to ER-Tbx2(1-301mt) (Supplemental Figure 3 for full gene
list). Although other cofactors in addition to Rb1 may play a
role, the regulation of these genes correlates with the capac-
ity of Tbx2(1-301) to bind Rb1. Principal component analysis
(PCA) of ER-Tbx2(1-301)– and ER-Tbx2(1-301mt)–express-
ing cells revealed that the three replicates from each cell line
cluster together and that there large differences between the
transcriptomes of ER-Tbx2(1-301) and ER-Tbx2(1-301mt)
cells (Figure 5A). These microarray experiments cannot dis-
criminate between direct and indirect target genes but
clearly demonstrate differences in expression programs be-
tween cells expressing the activated ER-Tbx2(1-301) and
ER-Tbx2(1-301mt) proteins, suggesting that Rb1 is able to
modulate Tbx2 target gene selection.
The ER-Tbx2(1-301) responsive gene list was sorted
based on biological function using GO annotation and
was found to be highly enriched for regulators of DNA
replication (p  1.15E-13) and cell division (p  1.55E-06).
These include Chaf1b, Cdt1, Cdkn2c, and components of
the Mcm complex, as well as Smc2, Prc1, Bub1, and the
Aurkb and Plk1 kinases. Figure 5B shows a heat map
displaying the relative expression levels of the 38 identi-
fied cell cycle control genes (GO:0007049) in our dataset in
each of the three replicates for each state. This revealed
that the expression of many positive regulators of cell
cycle was decreased and that the levels of several cell
cycle inhibitors increased after induction of the Tbx2(1-
Figure 4. Generation and characterization of B16 cell lines express-
ing ER-Tbx2(1-301) and ER-Tbx2(1-301mt) proteins. (A) Rb1 en-
hances the DNA-binding activity of a Tbx2(1-301) but not Tbx2(1-
301mt) protein. Bandshift assay in which suboptimal levels of
purified GST-Tbx2(1-301) and GST-Tbx2(1-301mt) fusion proteins
were incubated with a consensus T-element probe and increasing
concentrations of purified His-Rb(379-928). Western blotting (B)
using anti-HA or anti-tubulin antibodies and immunofluorescence
staining (C) with an anti-HA antibody showing the levels and
subcellular localization of ER-Tbx2(1-301) and ER-Tbx2(1-301mt)
proteins grown in the absence or presence of 4-OHT for 24 h.
Table 1. List of known Rb1-repressed genes identified as potential
Tbx2 targets
DNA replication/repair Mitosis
Chromatin/epigenetic
regulation
Lig1 CyclinB1 Dnmt1
Mcm2 Cdc2a Np95*
Mcm6 Plk Ezh2
Mcm7 Prc1 Hmgb2
CyclinA2 Bub1* Asf1b
Top2a
PCNA
Rrm1
Boldface indicates genes that are targeted by ER-Tbx2(1-301) but not
by the ER-Tbx2(1-301mt) protein, which does not bind Rb1. Aster-
isks mark genes that are not regulated by E2F.
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301) molecule, consistent with the previously identified
function of Tbx2 as an antisenescence factor (Vance et al.,
2005). Importantly, 24 of these cell cycle genes (Figure 5B,
shown in bold) were differentially expressed between the
ER-Tbx2(1-301) and ER-Tbx2(1-301mt) cell lines grown in
the presence of ligand, suggesting that their regulation
was dependent on the ability of Tbx2 to interact with Rb1.
GO annotation (GO:0006350) was also used to gain a
further understanding of the role of Tbx2 in transcription
control (Figure 5C). ER-Tbx2(1-301) induction increased
the expression of 18 transcriptional regulators and down-
regulated a further 21. These included genes that have
been implicated in the control of cellular proliferation,
differentiation, and cancer, such as members of the E2F
family, the Elk3 ETS domain factor, ATF-3 and -5, the
forkhead factor FoxM1, the Ezh2 polycomb protein, and
the DNA methyltranfserase Dnmt1. Consistent with a role
for Rb1 in modulating Tbx2 target specificity and func-
tion, 21 genes in this cluster were also differentially reg-
ulated by ER-Tbx2(1-301) induction but not by ER-Tbx2(1-
301mt). Taken together these results lead to the large-scale
identification of novel downstream Tbx2 effectors and
show that a mutation that disrupts the Rb1-Tbx2 interac-
tion leads to altered recognition and regulation of target
genes.
DISCUSSION
The T-box family of transcription factors is defined by
homology to the DNA-binding domain or T-box. How-
ever, individual T-box family members can recognize and
regulate different sets of target genes. Identification of the
molecular mechanisms controlling target gene selectivity
and transcriptional control is therefore essential to under-
stand the function of this family of transcription factors in
development and disease. The functional specificity of
T-box transcription factors is determined by a number of
factors. The prototypical T-box region from the brachyury
protein can bind the palindromic consensus T-element as
a dimer and can interact with individual half sites as a
monomer. However, x-ray crystallographic studies have
indicated that the T-box domain only makes two base-
specific contacts per half site (Muller and Herrmann,
1997), suggesting that additional mechanisms may play a
role in determining specificity. In fact, various family
members have been reported to display differing prefer-
ences for the number, position, and spacing of T-element
half sites within the regulatory regions of potential target
genes (Sinha et al., 2000; Conlon et al., 2001). Such differ-
ential target recognition could feasibly be regulated
through protein–protein interactions with DNA-binding
proteins and cofactors such as Rb1.
Figure 5. Rb1 modulates Tbx2(1-301) target gene specificity. (A) PCA analysis reveals large transcriptomic differences between ER-Tbx2(1-
301)– and ER-Tbx2(1-301mt)–induced cells. (B and C) Heat map displaying gene expression changes of cell cycle (GO:0007049) and
transcription factor (GO:0006350) genes after ER-Tbx2(1-301) induction. Green-to-red shift indicates repressed and red-to-green shift marks
up-regulated genes. Some targets are present in both categories. Genes indicated in bold are differentially expressed between ER-Tbx2(1-301)–
and ER-Tbx2(1-301mt)–induced cells.
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Interactions between T-box factors and other transcription
factors have been shown to contribute to target gene regu-
lation. Indeed, the T-box can bind the homeodomain from a
number of different homeobox factors. Tbx5 and Nkx2-5
interact and synergistically activate cardiac gene expression
(Hiroi et al., 2001) and Tbx2 binds and enhances Msx1-
mediated repression of the Cx43 promoter (Boogerd et al.,
2008), whereas Tpit activates POMC expression in coopera-
tion with Pitx1 (Lamolet et al., 2001). Factors contributing to
DNA specificity also reside outside the T-box. For example,
the Xenopus brachyury protein (Xbra), via its amino-termi-
nus, interacts with Smad1 to up-regulate expression of the
Xom homeobox gene (Messenger et al., 2005). Although the
Xom promoter contains a consensus T-element, mutated
variants of Xbra that are unable to bind Smad1 but have an
intact T-box do not induce Xom expression, suggesting that
the DNA-binding activity of the T-box can be modulated by
additional regulatory domains within the protein. This is
consistent with our findings that Rb1 interacts with Tbx2 via
a domain immediately C-terminal to the T-box and that a
mutation which disrupts the Rb1-Tbx2 interaction also af-
fects Tbx2 target gene specificity. The organization and
modification status of the chromatin at target gene loci may
also contribute to specificity as several T-box factors have
been shown to bind condensed chromatin. T-bet can bind to
a T-element half site within the interferon- promoter even
when this gene is epigenetically silenced by DNA methyl-
ation (Tong et al., 2005), and Tbx2 has been shown to colo-
calize with pericentric heterochromatin in the developing
mouse brain (Demay et al., 2007). The discovery that Rb1
interacts with and modulates Tbx2 target gene selectivity
therefore provides an important insight into the molecular
mechanisms controlling T-box functional specificity.
The transcription program regulated by Tbx2 is poorly
understood. Our microarray analysis extends the repertoire
of potential Tbx2 targets and enhances our understanding
Tbx2 function. We identify 38 cell cycle control genes and 39
transcription factors whose expression changes after induc-
tion of a ER-Tbx2(1-301) fusion protein containing the Tbx2
T-box and the surrounding sequence. The differential regu-
lation of 24 cell cycle and 21 transcription factor genes in this
set was shown to be dependent on the ability of Tbx2(1-301)
to interact with Rb1. Several studies have demonstrated that
Tbx2 directly represses p19ARF and p21CIP1 expression to
induce senescence in a variety of cell types (Jacobs et al.,
2000; Lingbeek et al., 2002; Prince et al., 2004; Vance et al.,
2005). Although our microarray analysis identified several
known Tbx2 targets such as connexin43, the expression of
p19ARF and p21CIP1 did not change in this experiment. We
did not expect to find changes in p19ARF expression because
the CDKN2a locus is deleted in B16 cells (Melnikova et al.,
2004). In the case of p21CIP1, a known Tbx2 target in B16
cells, it is important to note that we carried out our microar-
ray profiling of ER-Tbx2(1-301)–expressing cells after 24 h of
4-OHT induction in contrast to our previous analysis where
we measured changes in p21CIP1 expression after inducing
ER-Tbx2(1-301) for 4 d (Vance et al., 2005). We detected an
increase in p21CIP1 proteins levels by Western blotting after
2 d of ER-Tbx2(1-301) induction using the clonal cell line
described in this article (data not shown), which is consistent
with the finding that Tbx2 represses p21CIP1 expression. Our
results here also suggest that Tbx2 can regulate the expres-
sion of the p18INK4c cyclin-dependent inhibitor and the A2
and B1 type cyclins as well other cell cycle control kinases
such as bub1, plk1, chk1, pkmyt1, and aurkb, potentially
targeting the cell cycle machinery at additional points. We
also identified 18 previously known targets of Rb1-mediated
transcriptional repression in our microarray analysis whose
expression specifically changes after ER-Tbx2(1-301) induc-
tion. These genes can be grouped into important regulators
of DNA replication/repair and the G2-M phase transition
and factors that target chromatin to control gene expression.
The majority these genes are bound by E2F family members
(Ishida et al., 2001; Muller et al., 2001; Polager et al., 2002; Ren
et al., 2002), suggesting that Tbx2 and E2F may coregulate
the expression of specific sets of genes. However, the Bub1
and Np95 genes are repressed by Rb1 but are not E2F
targets, suggesting that Rb1 has additional functions in tran-
scriptional control independent of E2F that may involve
Tbx2.
The interaction between Tbx2 and Rb1 is likely to be
tightly regulated during cellular proliferation and differen-
tiation in response to growth signals and external stimuli. It
is well described that the activity of Rb1 is controlled by cell
cycle–dependent phosphorylation (for a review see Mitt-
nacht, 1998) and our results suggest that Tbx2 associates
with the active hypophosphorylated form of Rb1 that is
present in early to midG1 phase of the cell cycle and in late
mitosis. However, Tbx2 proteins levels are regulated during
cell cycle progression (Bilican and Goding, 2006). In B16
melanoma cells, MCF-7 breast cancer cells, and MRC-5 lung
fibroblasts, Tbx2 levels are low in G1 and rise in mid-S phase
with a peak of expression in G2 before being rapidly de-
graded at the onset of mitosis. It has also been suggested
that, in some cancers, Tbx2 protein is not degraded after G2,
resulting in mitotic defects and polyploidy (Davis et al.,
2007). We therefore speculate that Tbx2 and Rb1 may have
other functions in addition to the control of cellular prolif-
eration. Tbx2 and Rb1 may function in a checkpoint control
pathway. Consistent with this we find that ER-Tbx2(1-301)
expression misregulates the expression of the Chk1, E2F1,
E2F 8, Ddit3, Aurkb, Tipin, and Lig1 genes, which play a role
mediating the response to DNA-damaging agents and/or
apoptotic stimuli. Various studies have also described the
accumulation of hypophosphorylated Rb1 in response to
cellular stress. Specifically, hypophosphorylated Rb1 has
been shown to accumulate in late G1 and S phase in re-
sponse to -irradiation (Linke et al., 1997) and is induced in
S and G2 by hypoxia (Amellem et al., 1996). This possibility
is supported by the observation that Tbx2 function can be
regulated by stress-induced signaling pathways. Tbx2 is
phosphorylated by the p38 mitogen-activated protein kinase
in response to UV irradiation in breast cancer cell lines.
Phosphorylation stabilizes Tbx2 protein levels and increases
its transcriptional repressor function (Abrahams et al., 2008).
It is also likely that Tbx2 and Rb1 may cooperate to control
cellular growth and differentiation. Studies in a number of
different cell types have shown that hypophosphorylated
Rb1 accumulates upon differentiation and interacts with
different transcription factors to promote cell cycle exit, in-
duce tissue specific gene expression, and play a role in the
maintenance of the differentiated state (reviewed in Lipinski
and Jacks, 1999). Rb1 may modulate Tbx2 function during
development and differentiation in a manner analogous to
its regulation of the HMG box transcriptional repressor
HBP1 (Lavender et al., 1997; Tevosian et al., 1997). HBP1 has
a dual role in the control of proliferation and differentiation
and can transform cells in culture. HBP1 and E2F both
regulate the expression of the important cell cycle regulator
N-Myc but have opposing effects (Tevosian et al., 1997).
HBP1-mediated repression of N-myc is enhanced by Rb1
association, whereas Rb1 blocks E2F-mediated activation of
N-myc expression. In C2C12 myoblasts HBP1 overexpres-
sion inhibits the expression of N-myc and induces cell cycle
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exit but also blocks differentiation by repressing the expres-
sion of specific myogenic regulatory factors (Tevosian et al.,
1997; Shih et al., 1998). It is of interest to note that in addition
to functioning in cell cycle control Tbx2 has been shown to
regulate the expression of the TRP-1 pigmentation gene,
which is involved in melanocyte differentiation (Carreira et
al., 1998). Thus, the balance between the levels of active Rb1
and Tbx2 during development or in disease may control
Tbx2 target gene recognition and regulation and lead to
distinct downstream effects.
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